Baynes Roy D.
Insider CIK 1680739 · RTRX Director · NRIX Director · ATRA Director · NTRA Director · AARD Director · EIKN Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics, Inc | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | A Award deriv | 2026-08-14 | 2026-08-21 | 44,964 | — | $0 | 44,964 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2026-06-26 | 2026-06-30 | 1,571 | — | $0 | 20,083 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2026-06-26 | 2026-06-30 | 75 | — | $0 | 20,158 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-06-12 | 2026-06-16 | 4,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-06-12 | 2026-06-16 | 4,500 | $21.38 | $96.2K | 46,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-06-12 | 2026-06-16 | 4,500 | $50.00 | $225.0K | 41,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 41,500 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-05 | 2026-05-06 | 4,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-05 | 2026-05-06 | 4,500 | $46.65 | $209.9K | 37,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-05 | 2026-05-06 | 4,500 | $18.27 | $82.2K | 42,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-01 | 2026-05-04 | 9,750 | — | $0 | 9,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-01 | 2026-05-04 | 9,750 | $6.82 | $66.5K | 47,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-04 | 9,750 | $44.22 | $431.1K | 37,500 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2026-04-24 | 2026-04-28 | 83 | — | $0 | 18,512 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 8,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 9,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 4,500 | — | $0 | 4,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 4,500 | — | $0 | 4,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 6,750 | — | $0 | 6,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 8,000 | $17.94 | $143.5K | 45,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 9,000 | $15.43 | $138.9K | 54,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 4,500 | $18.27 | $82.2K | 59,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 4,500 | $21.38 | $96.2K | 63,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 6,750 | $17.11 | $115.5K | 70,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 6,750 | $42.12 | $284.3K | 37,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 26,000 | $41.07 | $1.07M | 44,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-06 | 2026-04-07 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-06 | 2026-04-07 | 10,000 | $26.52 | $265.2K | 47,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-06 | 2026-04-07 | 10,000 | $33.00 | $330.0K | 37,500 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 134,088 | — | $0 | 134,088 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2026-01-30 | 2026-02-03 | 70 | — | $0 | 18,429 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2025-11-20 | 2025-11-21 | 600 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2025-11-20 | 2025-11-21 | 7,068 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-20 | 2025-11-21 | 1,184 | $220.14 | $260.6K | 24,843 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2025-11-20 | 2025-11-21 | 600 | $40.93 | $24.6K | 18,959 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2025-11-20 | 2025-11-21 | 7,068 | $41.19 | $291.1K | 26,027 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-20 | 2025-11-21 | 900 | $221.81 | $199.6K | 23,943 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-20 | 2025-11-21 | 1,800 | $222.90 | $401.2K | 22,143 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-20 | 2025-11-21 | 1,884 | $224.89 | $423.7K | 18,359 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-20 | 2025-11-21 | 1,900 | $223.90 | $425.4K | 20,243 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2025-11-19 | 2025-11-21 | 5,112 | — | $0 | 600 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-19 | 2025-11-21 | 1,727 | $214.79 | $370.9K | 20,494 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-19 | 2025-11-21 | 2,135 | $216.07 | $461.3K | 18,359 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2025-11-19 | 2025-11-21 | 1,250 | $213.47 | $266.8K | 22,221 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2025-11-19 | 2025-11-21 | 5,112 | $40.93 | $209.2K | 23,471 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-10-31 | 2025-11-04 | 93 | — | $0 | 18,359 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-07-25 | 2025-07-29 | 108 | — | $0 | 18,266 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-06-27 | 2025-07-01 | 2,143 | — | $0 | 18,158 | SEC↗ |
| AARD Aardvark Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 30,508 | — | $0 | 30,508 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 37,500 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-04-25 | 2025-04-29 | 116 | — | $0 | 16,015 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2025-03-11 | 2025-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-06 | 2025-02-10 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-06 | 2025-02-10 | 10,000 | $22.00 | $220.0K | 31,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-06 | 2025-02-10 | 10,000 | $17.44 | $174.4K | 41,000 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-01-31 | 2025-02-04 | 92 | — | $0 | 15,899 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-01-23 | 2025-01-23 | 16,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-01-23 | 2025-01-23 | 16,000 | $20.00 | $320.0K | 31,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-01-23 | 2025-01-23 | 16,000 | $17.50 | $280.0K | 47,000 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2024-11-15 | 2024-11-15 | 22,000 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2024-11-15 | 2024-11-15 | 15,230 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2024-11-15 | 2024-11-15 | 15,230 | $24.42 | $371.9K | 53,037 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2024-11-15 | 2024-11-15 | 22,000 | $22.83 | $502.3K | 37,807 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2024-11-15 | 2024-11-15 | 5,500 | $144.26 | $793.4K | 47,537 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2024-11-15 | 2024-11-15 | 1,983 | $149.98 | $297.4K | 15,807 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2024-11-15 | 2024-11-15 | 2,106 | $148.74 | $313.2K | 17,790 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2024-11-15 | 2024-11-15 | 1,770 | $146.26 | $258.9K | 29,363 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2024-11-15 | 2024-11-15 | 9,467 | $147.31 | $1.39M | 19,896 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2024-11-15 | 2024-11-15 | 16,404 | $145.21 | $2.38M | 31,133 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-10-25 | 2024-10-29 | 124 | — | $0 | 15,807 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-07-26 | 2024-07-30 | 143 | — | $0 | 15,683 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-06-28 | 2024-07-02 | 2,964 | — | $0 | 15,540 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 31,000 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-04-26 | 2024-04-30 | 169 | — | $0 | 12,576 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-01-26 | 2024-01-30 | 215 | $63.79 | $13.7K | 12,407 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-10-27 | 2023-10-31 | 322 | $42.60 | $13.7K | 12,192 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-07-28 | 2023-08-01 | 264 | $48.48 | $12.8K | 11,870 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 4,255 | — | $0 | 4,255 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-06-30 | 2023-07-05 | 2,750 | — | $0 | 11,606 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2023-05-25 | 2023-05-26 | 3,534 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2023-05-25 | 2023-05-26 | 3,534 | — | $0 | 8,856 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 24,500 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-04-14 | 2023-04-18 | 228 | $54.73 | $12.5K | 5,322 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-01-13 | 2023-01-18 | 312 | $40.01 | $12.5K | 5,094 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2022-10-14 | 2022-10-18 | 275 | $45.42 | $12.5K | 4,782 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2022-07-08 | 2022-07-12 | 344 | $36.31 | $12.5K | 344 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2022-07-08 | 2022-09-02 | 344 | — | $0 | 4,507 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-06-23 | 2022-06-27 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-06-23 | 2022-06-27 | 20,500 | — | $0 | 43,500 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2022-05-27 | 2022-06-01 | 3,534 | — | $0 | 3,534 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2022-05-27 | 2022-06-01 | 7,068 | — | $0 | 7,068 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 1,307 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 1,307 | — | $0 | 4,163 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 20,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-06-08 | 2021-06-09 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-06-08 | 2021-06-09 | 11,000 | — | $0 | 23,000 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2021-05-28 | 2021-06-02 | 2,856 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2021-05-28 | 2021-06-02 | 1,307 | — | $0 | 1,307 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2021-05-28 | 2021-06-02 | 2,614 | — | $0 | 2,614 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2021-05-28 | 2021-06-02 | 2,856 | — | $0 | 2,856 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 17,000 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2020-08-07 | 2020-08-11 | 1,300 | — | $0 | 15,230 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2020-08-07 | 2020-08-11 | 1,300 | $53.47 | $69.5K | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2020-08-07 | 2020-08-11 | 1,300 | $24.42 | $31.7K | 1,300 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-06-16 | 2020-06-17 | 24,500 | — | $0 | 24,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2020-06-16 | 2020-06-17 | 8,000 | — | $0 | 12,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 5,712 | — | $0 | 5,712 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 2,856 | — | $0 | 2,856 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 14,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-06-27 | 2019-07-01 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-06-27 | 2019-07-01 | 4,000 | — | $0 | 4,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2019-05-24 | 2019-05-29 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 11,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2018-09-14 | 2018-09-18 | 16,530 | — | $0 | 16,530 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-09-11 | 2018-09-12 | 16,500 | — | $0 | 16,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 6,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-07-19 | 2016-07-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2016-07-19 | 2016-07-26 | 4,000 | — | $0 | 4,000 | SEC↗ |